Search products

Search by product name, CAT, CAS, molecular formula or chemical name.

Trusted Partner for Reference Standards and Beyond
Products About us Facility Quality system OUR DIVISIONS SimSon Chemtech Speciality & fine chemicals SimSon Chemie Research chemicals supply SimSon Lifescience Services CRO, CDMO & analytical testing Contact us Careers
Home/ Products/ Lenvatinib/ Carbamoyl Derivative Of Lenvatinib

Carbamoyl Derivative Of Lenvatinib

Structure of Carbamoyl Derivative Of Lenvatinib
CAT. No. L840028
CAS No. NA
Mol. Formula C25H24ClN5O5
Mol. Weight 509.94 g/mol
Chemical Name 4-(3-Chloro-4-[(cyclopropylcarbamoyl)amino]phenoxy)-N-(cyclopropylcarbamoyl)-7-methoxyquinoline-6-carboxamide
Synonyms NA
Smiles Code
Stock Status Under Synthesis

Technical Description

Carbamoyl Derivative Of Lenvatinib is listed by Simson Pharma as a impurity standards for laboratory research, analytical development and quality-control workflows.

Suitability is method- and purpose-specific. Before use, verify the product name, catalogue number, chemical identifiers, storage requirements and the information reported in the current product or batch documentation. Your laboratory remains responsible for method qualification or validation.

Product Applications & Regulatory Search Terms:

Carbamoyl Derivative Of Lenvatinib for method validation Carbamoyl Derivative Of Lenvatinib reference standard Carbamoyl Derivative Of Lenvatinib for ANDA filing Carbamoyl Derivative Of Lenvatinib for forced degradation studies Carbamoyl Derivative Of Lenvatinib identification standard Carbamoyl Derivative Of Lenvatinib for DMF filing Carbamoyl Derivative Of Lenvatinib HPLC standard Carbamoyl Derivative Of Lenvatinib supplier Carbamoyl Derivative Of Lenvatinib manufacturer Carbamoyl Derivative Of Lenvatinib distributor

Search COA by Batch No.

Find the Certificate of Analysis for a specific product batch.

Request a quote

Tell us what you need. Our technical desk normally replies within one working day.

Request a quote for Carbamoyl Derivative Of Lenvatinib

Share the required quantity, destination, intended analytical use and supporting documents you need. The technical desk will confirm the applicable product details, availability and quotation.

FOR INTERNATIONAL +91 87673 60663 info@simsonpharma.com
Technical desk · Mon–Sat, 09:30–18:30 IST
Carbamoyl Derivative Of Lenvatinib · L840028
PRODUCT NAME
This form is protected by server-side validation, rate limiting and spam detection. By sending it, you agree to our privacy policy.
We reply within one working day.
DISCLAIMER This page supports product identification and initial technical evaluation. Specifications, assigned values, pack options, availability and documentation may vary by product or batch; verify the applicable details in the current quotation, label and supplied records before use. The purchaser or importer is responsible for determining method suitability and meeting local regulatory, transport and import requirements. For research, analytical and quality-control use only. Not for human or veterinary consumption, and not for use as a medicine.
Carbamoyl Derivative Of Lenvatinib CAT. No. L840028 · CAS NA · 509.94 g/mol
✕
Structure of Carbamoyl Derivative Of Lenvatinib

Sample structure

Catalogue no.: — CAS no.: — Formula: — Mol. weight: —

Illustrative sample structure
SimSon — Science Standards Solutions
D-U-N-S Registered — Dun & Bradstreet D-U-N-S® REGISTERED Verified by Dun & Bradstreet
OFFICES & LABORATORIES
REGISTERED OFFICE · MUMBAI B-307, Sarita Building, Prabhat Industrial Estate, Near Dahisar Toll Naka, Dahisar (East), Mumbai- 400068, Maharashtra, India
CORPORATE OFFICE · MUMBAI Unit 1001-1006, The Platina, Tanvi Complex, S. V. Road, Dahisar East, Mumbai 400068, India
LABORATORY · HYDERABAD Shed 6A, TYPE III, TSIIC, Prashanthi Nagar, Kukatpally, Hyderabad 500072, India
REGIONAL OFFICE · AHMEDABAD Survey Number 375 Paiki 1, Plot Number 11, Shivam 5, Near Sumip Composite, Panchratna Estate, Village Changodar, Taluka Sanand, District Ahmedabad, Gujarat-382213
TALK TO THE RIGHT DESK
© 2026 SimSon Pharma Limited · All rights reserved